[1]
Farzad Allameh and S. A. Hojjati, “Advantages and Disadvantages of Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer”, Arch Men Health, vol. 8, no. 1, p. e14, Jun. 2025.